these IPR genes in a pals-22 mutant background back to near wild-type levels.
144
Importantly, a non-IPR gene, skr-1, is not affected by mutations in pals-22 or pals-25.
145
These results indicate that in a pals-22 mutant background, wild-type pals-25 activates 146 IPR gene expression.
148
Previous analysis indicated that pals-22 is broadly expressed in several tissues in the 149 animal, including the intestine and the epidermis [6, 8] . Similarly, we found that pals-25 is 150 broadly expressed. Using a fosmid containing pals-25 with endogenous cis regulatory 151 control and tagged at the C terminus with GFP and 3xFLAG [11] , we observed PALS- proteasome blockade, which is another trigger of IPR gene expression [9] (Fig 2C) . We 169 used bortezomib, which is a small molecule inhibitor of the 26S proteasome. Here again, 170 we found that bortezomib treatment induced IPR gene expression in pals-22 pals-25 171 mutants at levels similar to wild-type animals. Therefore pals-22/25 appear to regulate 172 IPR gene expression in parallel to infection and proteasomal stress. pals-22 mutants have several striking physiological phenotypes, including slowed growth 177 and shorter lifespans, as well as increased resistance to proteotoxic stress like heat 178 shock [6] . Therefore, we investigated whether mutations in pals-25 suppress these 179 phenotypes of pals-22 mutants. First, we investigated developmental rate by measuring 180 the fraction of animals that reach the fourth larval (L4) stage by 48 hours after 181 embryogenesis. Nearly all wild-type animals are L4 at this timepoint, whereas less than 182 20% of pals-22 mutants are L4 ( Fig 3A) . We found that mutations in pals-25 completely 183 reverse this delayed development of pals-22 mutants, with nearly all pals-22 pals-25 184 mutants reaching the L4 stage by 48 hours (Fig 3A) . Next, we analyzed lifespan, as 185 previous work showed that pals-22 mutants have a significantly shortened lifespan 186 compared to wild-type animals [6, 8] . Here again we found that pals-25 mutations 187 reversed this effect, with pals-22 pals-25 mutants having lifespans comparable to wild-188 type animals ( Fig 3B, S3A-B Fig) . Next, we investigated the effect of pals-25 mutations 189 on the thermotolerance capacity of pals-22 mutants, which is greatly enhanced 190 compared to wild-type animals. We found that pals-22 pals-25 double mutants have 191 survival after heat shock at levels similar to wild-type animals (Fig 3C, S3C-D Fig) ,
192
indicating that pals-25 is required for the enhanced thermotolerance of pals-22 mutants.
193
Thus, these results show that in a pals-22 mutant background, wild-type pals-25 is 194 required to delay development, shorten lifespan and enhance thermotolerance.
196
Previous work from the Hobert lab identified pals-22 in a screen for regulators of reporter 197 gene expression in neurons [8] . They found that mutations in pals-22 led to decreased 198 levels of GFP reporter expression in neurons and other tissues, and wild-type pals-22 199 thus acts as an 'anti-silencing' factor of multi-copy transgene expression. Therefore, we 200 analyzed the effects of pals-25 mutations on transgene silencing in pals-22 mutants.
201
Here we found that pals-25 mutations reverse the enhanced silencing of a neuronally 202 expressed GFP transgene in pals-22 mutants ( Fig 3D-I) , indicating that wild-type pals-25 203 activity is required to silence expression from multi-copy transgenes in a pals-22 mutant 204 background. Of note, previous work found that a pals-25 mutation alone does not affect 205 transgene silencing [8] . In summary, mutations in pals-25 appear to fully reverse all 206 previously described phenotypes of pals-22 mutants. 207 208 pals-22 mutants have immunity against coevolved intestinal pathogens of the 209 intestine, which is suppressed by pals-25 mutations 210 In addition to the previously described phenotypes of pals-22 mentioned above, we 211 analyzed resistance of these mutants to intracellular infection. First we analyzed the 212 resistance of pals-22 mutants to N. parisii infection. We fed animals a defined dose of 213 microsporidia spores and measured pathogen load inside intestinal cells. We analyzed 214 pathogen load at 30 hours post infection (hpi), when N. parisii is growing intracellularly in 215 the replicative meront stage, and found greatly lowered pathogen load in pals-22 216 mutants compared to wild-type animals ( Fig 4A-F) . We then tested pals-22 pals-25 217 double mutants and found these animals to have resistance comparable to wild-type.
218
One explanation for the altered levels of N. parisii observed in the intestines of pals-22 219 mutant animals is that these mutants have lowered feeding or accumulation of pathogen 220 in the intestine, and thus simply have a lower exposure to N. parisii. To address this 221 concern, we added fluorescent beads to our N. parisii infection assay and measured 222 accumulation in the intestinal lumen. Here we found that pals-22 mutants and pals-22 223 pals-25 double mutants accumulated fluorescent beads at comparable levels to wild-type 224 animals (S4A Fig) , suggesting that their pathogen resistance to N. parisii is not simply 225 due to lowered exposure to the pathogen in the intestinal lumen. As a positive control in 226 this assay we tested eat-2(ad465) mutants and found that they had reduced fluorescent 227 bead accumulation, consistent with their previously characterized feeding defect [13] .
228
Altogether, these results indicate that pals-22 and pals-25 regulate resistance to 229 infection by microsporidia.
231
We also investigated resistance of pals-22 mutants and pals-22 pals-25 double mutants 232 to other pathogens. First, we measured resistance to infection by the Orsay virus. Like 233 N. parisii, Orsay virus is a natural pathogen of C. elegans, and replicates inside of C. 234 elegans intestinal cells [14] . We used FISH staining of Orsay viral RNA to quantify the 235 fraction of worms infected at 18 hpi. Here we found that pals-22 mutants had significantly 236 decreased viral load when compared to wild-type animals ( Fig 4G-L) . This lowered viral 237 infection in pals-22 mutants was fully reversed in pals-22 pals-25 mutants back to wild-238 type levels. Importantly, we confirmed that pals-22 and pals-22 pals-25 mutants do not 
243
Interestingly, we found that pals-22 mutants did not have reduced pathogen loads when 244 infected with the Gram-negative bacterial pathogen Pseudomonas aeruginosa (clinical 245 isolate PA14) ( Fig 4M) . In fact, these mutants had increased pathogen load, which was 246 suppressed by mutations in pals-25. To our knowledge P. aeruginosa species are not 247 common pathogens of nematodes in the wild, although under laboratory conditions, P.
248 aeruginosa PA14 does accumulate in the C. elegans intestinal lumen and causes a 249 lethal infection [15] . In summary pals-22 mutants have increased resistance to natural 250 pathogens of the intestine, but increased susceptibility to PA14, a 'non-natural' pathogen 251 of the intestine.
253

RNA-seq analysis of pals-22/25-upregulated genes define the IPR
254
Previous work indicated that N. parisii and the Orsay virus induce a common set of 255 genes, despite these being very different pathogens [9] . We called eight of these genes 256 the IPR subset [6] , and here we show they are regulated by pals-22/25 (Fig 2A) . To 257 identify additional genes regulated by pals-22/25, we performed RNA-seq analysis of 258 pals-22 mutants, pals-22 pals-25 mutants, and wild-type animals. We performed 259 differential gene expression analysis using a FDR<0.01 cutoff (see Materials and
260
Methods for a complete description of criteria) and determined that 2,756 genes were 261 upregulated in pals-22 mutants compared to wild-type animals ( Fig 5A, S7 Table) . Next 262 we compared pals-22 mutants to pals-22 pals-25 double mutants and found that 744 263 genes were upregulated (Fig 5A, S7 Table) . Of these two comparisons, there are 702 264 genes in common that are upregulated both in pals-22 mutants compared to wild-type 265 animals and in pals-22 mutants compared to pals-22 pals-25 double mutants ( Fig 5A) .
266
Therefore, these 702 genes are negatively regulated by wild-type pals-22 and require 267 the activity of the wild-type pals-25 for their induction in the absence of pals-22. These 268 702 genes include genes like our pals-5 reporter (Fig 1) and other IPR genes (Fig 2) .
270
We next compared these 702 pals-22/25 regulated genes to genes induced during N.
271
parisii infection identified in a previous study [9] to expand our list of IPR genes. Out of 272 127 genes induced during N. parisii infection we found that the pals-22/25 gene pair 273 regulated mRNA expression of 80 of these genes ( Fig 5A) . Specifically, of the 25 pals Table) .
276
Notably, all pals genes that are not regulated by pals-22/25 are also not induced by 277 infection. Furthermore, the other nematode-specific genes F26F2.1, F26F2.3, and 278 F26F2.4, which are induced by N. parisii and Orsay virus infection, were also found to be 279 induced in pals-22 mutants and brought back to wild-type levels in pals-22 pals-25 280 double mutants ( Fig 5C) . In addition, we found that the ubiquitin ligase components are 281 similarly regulated ( Fig 5D) . These studies thus define IPR genes as the 80 genes that Previous work indicated that blockade of the proteasome, either pharmacologically or 288 genetically, will induce expression of a subset of IPR genes [9] . To determine the IPR 289 genes that are induced by proteasome stress, we performed RNA-seq analysis to define 290 the whole-genome response to this stress. Again, we conducted differential expression 291 analysis and compared gene expression of animals after 4 hours of exposure to the 292 proteasome inhibitor bortezomib compared to the DMSO vehicle control. From these 293 experiments we determined that 988 genes are induced following bortezomib treatment, 294 using the cut-off mentioned above and described in the Materials and Methods.
295
Interestingly, nearly all of the IPR genes described above are also induced following 296 bortezomib treatment ( Fig 5E) . Previous work has shown that genes induced by N.
297
parisii do not include the proteasome subunits induced by proteasome blockade as part 298 of the bounceback response [9] . The bounceback response is induced via the 299 transcription factor SKN-1. Consistent with these results, here we find that the IPR genes 300 induced by bortezomib are distinct from those regulated by the transcription factor SKN-301 1, as defined by a previous study [16] . The overlap between SKN-1 regulated genes and
302
IPR genes includes only one gene ( Fig 5E) .
304
As shown earlier, pals-22 mutants have increased resistance to heat shock, and 305 previous work indicated that there is overlap between genes induced by chronic heat 306 stress and genes induced by N. parisii and virus infection [9] . However, the genes in 307 common are distinct from the canonical chaperones, or Heat Shock Proteins (HSPs), 308 which are induced by the heat shock transcription factor HSF-1. To learn more about the 309 connection between heat shock response, HSF-1, and the IPR, we compared the IPR 310 genes with those induced by HSF-1 as defined in a previous study [17] . Here we found 8 311 genes in common between our set of 80 IPR genes and the set of 368 genes 312 upregulated by HSF-1, none of which are predicted to encode chaperone proteins (S10 313   Table) . We also compared the 368 genes upregulated by HSF-1 with the 702 genes that 314 are regulated by pals-22/25 and found 59 genes in common (S10 Table) . These genes 315 include secreted C-type lectins and F-box genes, but do not include chaperones. In summary, HSF-1 regulates 59 genes in common with those regulated by pals-22/25, but 317 only 8 of these are IPR genes. 
336
The fungal pathogen Drechmeria coniospora infects and penetrates the epidermis of 337 nematodes, triggering a GPCR signaling pathway that upregulates expression of 338 neuropeptide-like (nlp) genes including nlp-29 to promote defense [15] . Our 339 transcriptome analysis shows that pals-22/25 regulate a significant number of genes in 340 common with Drechmeria infection (S10 Table) . Notably these genes do not include the well-characterized neuropeptide nlp defense genes, although they do include many of 342 the pals genes. A more recently described natural pathogen of C. elegans is 343 Myzocytiopsis humicola, which is an oomycete that also infects through the epidermis 344 and causes a lethal infection [19] . Here as well, pals-22/25 regulate a significant number 345 of genes in common with those induced by M. humicola infection, including the chitinase-346 like 'chil' genes that promote defense against this pathogen (S10 Table) . Interestingly, 347 these chil genes, like the pals genes, are species-specific [8, 19] .
349
We next used Ortholist [20] to determine which genes identified from our RNA-seq 350 analyses have predicted human orthologs. Of the 702 genes regulated by pals-22/25, 351 279 genes (39.7%) have predicted human orthologs (S11 Table) . In contrast, of the 368 352 genes induced in hsf-1 mutants 190 (51.6%) have predicted human orthologs.
353
Therefore, more of the genes regulated by the conserved transcription factor hsf-1 have 
370
We then used a pals-22; chil-27p::GFP strain for a suppressor screen, analogous to the 
375
These observations are consistent with our differential expression analysis, which 376 determined that chil-27 is induced in a pals-22 mutant background and that pals-25 is 377 required for this induction ( Fig 7C) . Therefore, pals-22/25 act as a switch not only for 378 genes induced in the intestine by natural intestinal pathogens, but also as a switch for 379 genes induced in the epidermis by natural epidermal pathogens of C. elegans.
381
Discussion
382
In many organisms, there is a balance between growth and pathogen resistance. In 383 particular, many studies in plants have indicated that genetic immunity to disease comes 384 at a cost to the yield of crops [21] . Here we define a program in C. elegans that controls 385 a balance between organismal growth with resistance to natural pathogens, which is 386 regulated by the pals-22/25 species-specific gene pair. These genes act as a switch 
451
Indeed, C. elegans lacks many PRR signaling pathways that are well described in flies 452 and mammals. For example, the C. elegans single Toll-like receptor tol-1 does not act 453 canonically and worms appear to have lost its downstream transcription factor NFkB, 454 which is critical for innate immunity in flies and mammals [30] . Perhaps conservation of 455 immune genes is only reserved for defense against rare, 'non-natural' pathogens, 456 because genes that are important for immunity are subject to attack and inhibition by 457 microbes [31]. Thus, immune genes that provide defense against natural pathogens from 458 the recent evolutionary past will not be broadly conserved but rather will be species-459 specific, like rapidly evolving R genes in plants. While R genes have been shown to 460 encode proteins that detect virulence factors secreted into host cells by co-evolved plant 461 pathogens, the mechanism by which they activate downstream immune signaling is 
486
We used N2 wild-type animals. Mutant or transgenic strains were backcrossed at least 487 three times. See S1 Table for a list of all strains used in this study.
489
EMS screens and cloning of alleles 490 pals-22 mutant worms (either the jy1 or jy3 allele) carrying the jyIs8[pals-5p::GFP, myo-491 2p::mCherry] transgene were mutagenized with ethyl methane sulfonate (EMS) (Sigma) 492 using standard procedures as described [34] . L4 stage P0 worms were incubated in 47 493 mM EMS for 4 hours at 20°C. Worms were screened in the F2 generation for decreased 494 expression of GFP using the COPAS Biosort machine (Union Biometrica).
495
Complementation tests were carried out by generating worms heterozygous for two 496 mutant alleles and scoring pals-5p::GFP fluorescence. For whole-genome sequencing 497 analysis of mutants, genomic DNA was prepared using a Puregene Core kit (Qiagen) 498 and 20X sequencing coverage was obtained. We identified only one gene (pals-25) on
499
LGIII containing variants predicted to alter function in both mutants sequenced (jy9 and 500 jy100). Additional pals-25 alleles were identified by Sanger sequencing. Screens in the 501 strains carrying the icbIs4[chil-27p::GFP, col-12p::mCherry] transgene were performed 502 in a similar manner except that we used 24 mM EMS to recover the pals-22 alleles 503 (icb88, icb90) and 17 mM EMS for the pals-22(icb90) suppressor screen and that in both 504 cases we selected F2 animals manually using a Zeiss Axio ZoomV16 dissecting scope.
505
The two pals-22 alleles (icb88, icb90) were identified by whole genome sequencing of 506 GFP positive F2 recombinants after crossing to the polymorphic isolate CB4856 as 507 previously described [35] whereas the two pals-25 alleles were found by direct 508 sequencing of the mutant strains. The pals-22(icb89) allele was identified by Sanger 509 sequencing. See S1 
533
Heat shock assay 534 Worms were grown on standard NGM plates until the L4 stage at 20°C and then shifted 535 to 37°C for two hours. Following heat shock, plates were laid in a single layer on the 536 bench top for 30 minutes to recover, and then moved to a 20°C incubator overnight.
537
Worms were scored in a blinded manner for survival 24 hours after heat shock; animals 538 not pumping or responding to touch were scored as dead. Three plates were assayed for 539 each strain in each replicate, with at least 30 worms per plate, and three independent 540 assays were performed. 
548
Lifespan 549 L4 stage worms were transferred to 6 cm NGM plates seeded with OP50-1 bacteria and 550 incubated at 25°C. Worms were scored every day, and animals that did not respond to 551 touch were scored as dead. Animals that died from internal hatching or crawled off the 552 plate were censored. Worms were transferred to new plates every day throughout the 553 reproductive period. Three plates were assayed for each strain in each replicate, with 40 554 worms per plate.
556
Microscopy 557 Worms were anesthetized with 10 μM levamisole in M9 buffer and mounted on 2% 558 agarose pads for imaging. Images in Figure S1B and S1C were captured with a Zeiss 559 LSM700 confocal microscope. All other C. elegans images were captured with a Zeiss 560 AxioImager M1 or Axio Zoom.V16. 561 562 N. parisii and Orsay virus infection assays 563 N. parisii spores were prepared as previously described [37] , and Orsay virions were 564 prepared as described previously [9] . For pathogen load analysis, synchronized L1 565 worms were plated with a mixture of OP50 bacteria and 5 x 10 5 N. parisii spores or a 566 1:20 dilution of Orsay virus filtrate, and then incubated at 25°C for either 30 hours (N. Overnight cultures of a P. aeruginosa PA14-dsRed strain [38] were seeded onto SK 580 plates with 50 μg/ml ampicillin, and then incubated at 37°C for 24 hours followed by 581 25°C for 24 hours. Worms at the L4 stage were washed onto the PA14-dsRed plates, 582 incubated at 25°C for 16 hours, and then assayed with a COPAS Biosort machine 583 (Union Biometrica) for the amount of red fluorescence inside each animal.
585
RNA-seq sample preparation 586 Synchronized L1 stage worms were grown on 10 cm NGM plates seeded with OP50-1 587 E. coli at 20°C until worms had reached the L4 stage. N2, pals-22(jy3), and pals-22(jy3) 588 pals-25(jy9) strains were then shifted to 25°C for 4 hours before harvesting for RNA 589 extraction. Bortezomib (or an equivalent amount of DMSO) was added to plates with L4 590 stage N2 worms for a final concentation of 20uM; plates were then incubated at 20°C for 591 4 hours before RNA isolation. RNA was isolated with TriReagent purification, followed by 592 RNeasy column cleanup (Qiagen), as described [39] . RNA quality was assessed by 593 Tapestation analysis at the Institute for Genomic Medicine (IGM) at UC San Diego. 
883
Black cells indicate no significant correlation was detected, a FDR>0.25, or p>0.05).
884
*FDR<0.05. For more detailed results, see S9 Table. For details on the gene sets used 885 see S8 Table. 886 887 Fig 7. pals-22 and pals-25 regulate expression of chil-27 in the epidermis.
888
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